NASDAQ: TENX

Tenax Therapeutics, Inc.

Healthcare | Biotechnology

No licensed closing price on file for TENX. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-1.49

Tenax Therapeutics, Inc. (NASDAQ: TENX) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 01:51 UTC.

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation	8-K 2026-07-02
EPS (TTM)	$-1.49

Charts

Charts are in the appInteractive charts for TENX are available in Oxford Ledge.
Open TENX in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-09-17

2026-09-17DirectorPurchase53,000$101.8K
2026-09-15Chief Financial OfficerPurchase5,675$11.0K
2026-09-15CEOPurchase4,850$8.8K

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

FMR LLC3,942,373$57.36M+1122.1%
Vivo Capital, LLC2,500,000$36.38M+1100.0%
BlackRock, Inc.1,727,988$25.14M+10078.4%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2026-04-22Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2026-01-09Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersStuart RichEstimatedSEC 8-K →
2024-12-04Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

Tenax Therapeutics (TENX) Securities Investigation Notice - Levi & Korsinsky
prnewswire.com2026-08-19NEG
STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study
STAT News2026-08-10
Tenax Therapeutics, Inc. (TENX) Discusses Phase III LEVEL Trial Results for Oral Levosimendan in HFpEF Patients Transcript
Seeking Alpha Feed2026-08-10
Tenax Therapeutics: Double Or Nothing (Rating Upgrade)
Seeking Alpha Feed2026-08-02POS
Tenax Therapeutics: 'Hold' TNX-103 Data August 2026 - But With Caution Ahead
seekingalpha.com2026-07-06

Questions this page answers

What does Tenax Therapeutics, Inc. do?

Tenax Therapeutics, Inc. is a biotechnology company, listed on NASDAQ as TENX.

When did TENX last file with the SEC?

Tenax Therapeutics, Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-02. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 01:51 UTC. This page is also available as JSON at /api/data?ticker=TENX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for TENX and 5,000+ tickers.

Create a free account — keep TENX

For your agent

GET /api/data?ticker=TENX

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt